Kathy Boltz, PhD | Authors

Articles

Nivolumab Combinations Feasible for Newly Diagnosed GBM

November 20, 2016

The PD-1 inhibitor nivolumab was successfully combined with radiotherapy alone or concurrently with temozolomide for patients with newly-diagnosed glioblastoma multiforme in cohorts 1c and 1d from the phase I CheckMate-143 study.